Stock Movers: Apple's Investment, Eli Lilly's Pill Data, and Trade Desk Competition

Apple's Manufacturing Investment

• 🍎 Apple (AAPL) shares saw a significant weekly gain, contributing substantially to the S&P 500's rise.
• 💡 This surge was driven by an announcement of an additional $100 billion investment in domestic manufacturing, aimed at mitigating future tariff costs.
• 📈 Despite the recent boost, Apple's stock is still down year-to-date, lagging behind its peers in the 'Mag Seven' and the broader market.

Eli Lilly's Weight Loss Pill Setback

• 📉 Eli Lilly (LLY) experienced its worst week since 2008, with shares dropping 18%.
• ⚠️ Investors reacted negatively to disappointing data from a study on their new weight-loss pill, which showed lower efficacy and higher side effects than anticipated.
• 💊 While the drug is still considered good, its performance is limited by its nature as a GLP-1 drug, according to analysts.
• 🚀 This news also positively impacted competitor Novo Nordisk.

Trade Desk Faces Amazon Competition Fears

• 📉 Trade Desk (TTD) stock plummeted 39% in a single day, marking its worst performance since 2016.
• 📊 The sharp decline followed results and a forecast that failed to impress Wall Street, coupled with growing concerns about competition from Amazon's advertising technology.
• 🔍 Analysts are worried about Amazon's improvements to its demand-side platform, which could impact Trade Desk's market share.
• 🗣️ The CEO's dismissal of Amazon as a competitor on an analyst call has raised further investor concerns.